Open AccessEfficacy and safety of Exifin<sup>®</sup> in treatment of mycoses of skin and nail plates
Author(s) -
Alexander B. Yakovlev
Publication year - 2019
Publication title -
medicinskij alfavit
Language(s) - English
Resource type - Journals
eISSN - 2949-2807
pISSN - 2078-5631
DOI - 10.33667/2078-5631-2019-2-26(401)-54-61
Subject(s) - nail (fastener) , dermatology , medicine , adverse effect , observational study , pyoderma , population , surgery , materials science , environmental health , metallurgy
The mycoses of the skin and nail plates of the feet are the second most common in the human population after pyoderma, and are the fact of a significant decrease in the quality of life of patients. In the present multicenter observational study, the results of the evaluation of the quality of life of 1 674 patients before and after successful treatment of mycosis of the skin and nails with the use of the drug Exifine®: showing a clear correlation between successful eradication of the pathogen and to improve the quality of life of the patient in all age groups. In no case was there any mention of adverse reactions to either the external or the systemic dosage form of the drug.